United States Biotechnology & Medical Research

Protara Therapeutics Inc (TARA)

Track

Protara Therapeutics experienced notable insider trading activity recently, characterized by a net negative value of approximately $882,160. CEO Jesse Shefferman executed a significant sale of 215,687 shares in late June. This divestment occurs amid a 13.7% decline in stock performance over the past quarter, following a missed earnings report.
Ticker: TARA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Protara Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.9
Shefferman Jesse CEO and President Executive Director
Transaction date
Sale
Price
262.18
Quantity 522 +30.6%
Value US$4,997,868
1.9
JESSE SHEFFERMAN Officer; Director Executive Director
Transaction date
Proposed sale
Price
157.99
Quantity 18,594
Value US$215,092
667, L.P. Former Affiliate
Transaction date
Proposed sale
Price
5.35
Quantity 24,802
Value US$132,691
Zummo Jacqueline Chief R&D Officer Officer
Transaction date
Planned sale
Price
5.40
Quantity 1,134 -1.2%
Value US$6,124
Zummo Jacqueline Chief R&D Officer Officer
Transaction date
Planned sale
Price
5.26
Quantity 22,598 -19.1%
Value US$118,865
Zummo Jacqueline Officer Officer
Transaction date
Proposed sale
Price
5.26
Quantity 23,732
Value US$124,826
667, L.P. Former Affiliate
Transaction date
Proposed sale
Price
5.85
Quantity 38,277
Value US$223,920
667, L.P. Former Affiliate
Transaction date
Proposed sale
Price
6.26
Quantity 35,173
Value US$220,151
667, L.P. Former Affiliate
Transaction date
Proposed sale
Price
5.81
Quantity 78,716
Value US$457,046
667, L.P. Former Affiliate
Transaction date
Proposed sale
Price
6.04
Quantity 26,755
Value US$161,584
3.5
Levy Richard S Non-Executive Director
Transaction date
Purchase
Price
3.19
Quantity 20,000 +64.5%
Value US$63,800
Zummo Jacqueline Chf Scientific Operations Off Officer
Transaction date
Planned sale
Price
4.53
Quantity 21,224 -17.7%
Value US$96,145
Zummo Jacqueline Officer Officer
Transaction date
Proposed sale
Price
4.55
Quantity 21,224
Value US$96,569
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Sale
Price
1.71
Quantity 119,801 -5.8%
Value US$204,728
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Sale
Price
3.11
Quantity 151,700 -6.0%
Value US$472,424
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
3.80
Quantity 2,300 +1.8%
Value US$8,740
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
3.80
Quantity 5,000 +0.2%
Value US$19,000
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
3.98
Quantity 2,500 +2.0%
Value US$9,950
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
3.98
Quantity 14,100 +0.6%
Value US$56,118
1.9
Shefferman Jesse CEO and President Executive Director
Transaction date
Purchase
Price
3.84
Quantity 9,065 +1.0%
Value US$34,810
2.4
BESHAR LUKE M Non-Executive Director
Transaction date
Purchase
Price
3.10
Quantity 10,000 +5.3%
Value US$31,000
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
4.80
Quantity 2,469 +105.4%
Value US$11,841
2.4
BESHAR LUKE M Non-Executive Director
Transaction date
Purchase
Price
4.25
Quantity 10,000 +5.6%
Value US$42,500
2.4
BESHAR LUKE M Non-Executive Director
Transaction date
Purchase
Price
4.46
Quantity 10,000 +6.0%
Value US$44,555
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
4.96
Quantity 4,031 +3.4%
Value US$20,007
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
4.96
Quantity 20,000 +0.8%
Value US$99,264
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
6.60
Quantity 2,300 +0.1%
Value US$15,180
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
6.41
Quantity 1,063 +1.0%
Value US$6,815
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
6.41
Quantity 6,500 +0.3%
Value US$41,670
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
6.98
Quantity 1,000 +1.0%
Value US$6,980
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
6.98
Quantity 14,206 +0.6%
Value US$99,151
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-01 2026-06-29 S Sale
1.9
Shefferman Jesse

CEO and President

Executive Director
522 +30.6%
262.18
US$4,997,868 		522 +30.6% 262.18 US$4,997,868
2026-06-29 2026-06-29 PrS Proposed sale
1.9
JESSE SHEFFERMAN

Officer; Director

Executive Director
18,594
157.99
US$215,092 		18,594 157.99 US$215,092
2026-04-23 2026-04-23 PrS Proposed sale
Baker Brothers Life Sciences, L.P.

Former Affiliate
77,487
45.71
US$810,660 		77,487 45.71 US$810,660
2026-04-23 2026-04-23 PrS Proposed sale
667, L.P.

Former Affiliate
24,802
5.35
US$132,691 		24,802 5.35 US$132,691
2026-04-09 2026-04-08 PlS Planned sale
Zummo Jacqueline

Chief R&D Officer

Officer
1,134 -1.2%
5.40
US$6,124 		1,134 -1.2% 5.40 US$6,124
2026-04-02 2026-04-01 PlS Planned sale
Zummo Jacqueline

Chief R&D Officer

Officer
22,598 -19.1%
5.26
US$118,865 		22,598 -19.1% 5.26 US$118,865
2026-04-01 2026-04-01 PrS Proposed sale
Zummo Jacqueline

Officer

Officer
23,732
5.26
US$124,826 		23,732 5.26 US$124,826
2026-03-06 2026-03-06 PrS Proposed sale
667, L.P.

Former Affiliate
38,277
5.85
US$223,920 		38,277 5.85 US$223,920
2026-03-06 2026-03-06 PrS Proposed sale
Baker Brothers Life Sciences, L.P.

Former Affiliate
461,723
5.85
US$2,701,080 		461,723 5.85 US$2,701,080
2026-03-04 2026-03-04 PrS Proposed sale
667, L.P.

Former Affiliate
35,173
6.26
US$220,151 		35,173 6.26 US$220,151
2026-03-04 2026-03-04 PrS Proposed sale
Baker Brothers Life Sciences, L.P.

Former Affiliate
424,125
6.26
US$2,654,641 		424,125 6.26 US$2,654,641
2026-02-25 2026-02-25 PrS Proposed sale
667, L.P.

Former Affiliate
78,716
5.81
US$457,046 		78,716 5.81 US$457,046
2026-02-25 2026-02-25 PrS Proposed sale
Baker Brothers Life Sciences, L.P.

Former Affiliate
947,479
5.81
US$5,501,316 		947,479 5.81 US$5,501,316
2026-02-24 2026-02-24 PrS Proposed sale
667, L.P.

Former Affiliate
26,755
6.04
US$161,584 		26,755 6.04 US$161,584
2026-02-24 2026-02-24 PrS Proposed sale
Baker Brothers Life Sciences, L.P.

Former Affiliate
322,039
6.04
US$1,944,922 		322,039 6.04 US$1,944,922
2025-05-16 2025-05-14 B Purchase
3.5
Levy Richard S
Non-Executive Director
20,000 +64.5%
3.19
US$63,800 		20,000 +64.5% 3.19 US$63,800
2025-03-28 2025-03-26 PlS Planned sale
Zummo Jacqueline

Chf Scientific Operations Off

Officer
21,224 -17.7%
4.53
US$96,145 		21,224 -17.7% 4.53 US$96,145
2025-03-26 2025-03-26 PrS Proposed sale
Zummo Jacqueline

Officer

Officer
21,224
4.55
US$96,569 		21,224 4.55 US$96,569
2024-09-12 2024-09-12 S Sale
3.4
Opaleye Management Inc.
Large shareholder
6,500 -12.6%
1.71
US$11,108 		6,500 -12.6% 1.71 US$11,108
2024-09-12 2024-09-12 S Sale
3.4
Opaleye Management Inc.
Large shareholder
119,801 -5.8%
1.71
US$204,728 		119,801 -5.8% 1.71 US$204,728
2024-09-12 2024-09-11 S Sale
3.4
Opaleye Management Inc.
Large shareholder
1,600 -3.0%
1.71
US$2,743 		1,600 -3.0% 1.71 US$2,743
2024-09-12 2024-09-11 S Sale
3.4
Opaleye Management Inc.
Large shareholder
31,000 -1.5%
1.71
US$53,137 		31,000 -1.5% 1.71 US$53,137
2024-09-10 2024-09-10 S Sale
3.4
Opaleye Management Inc.
Large shareholder
1,500 -2.7%
1.77
US$2,654 		1,500 -2.7% 1.77 US$2,654
2024-09-10 2024-09-10 S Sale
3.4
Opaleye Management Inc.
Large shareholder
24,000 -1.1%
1.77
US$42,456 		24,000 -1.1% 1.77 US$42,456
2024-09-10 2024-09-09 S Sale
3.4
Opaleye Management Inc.
Large shareholder
1,900 -3.4%
1.89
US$3,600 		1,900 -3.4% 1.89 US$3,600
2024-09-10 2024-09-09 S Sale
3.4
Opaleye Management Inc.
Large shareholder
34,592 -1.6%
1.89
US$65,541 		34,592 -1.6% 1.89 US$65,541
2024-07-18 2024-07-16 S Sale
3.4
Opaleye Management Inc.
Large shareholder
3,500 -5.8%
2.44
US$8,547 		3,500 -5.8% 2.44 US$8,547
2024-07-18 2024-07-16 S Sale
3.4
Opaleye Management Inc.
Large shareholder
7,896 -0.4%
2.44
US$19,281 		7,896 -0.4% 2.44 US$19,281
2024-07-11 2024-07-11 S Sale
3.4
Opaleye Management Inc.
Large shareholder
15,000 -20.0%
2.40
US$36,051 		15,000 -20.0% 2.40 US$36,051
2024-07-11 2024-07-11 S Sale
3.4
Opaleye Management Inc.
Large shareholder
32,993 -1.5%
2.40
US$79,295 		32,993 -1.5% 2.40 US$79,295
2024-07-11 2024-07-10 S Sale
3.4
Opaleye Management Inc.
Large shareholder
5,000 -6.2%
2.31
US$11,540 		5,000 -6.2% 2.31 US$11,540
2024-07-11 2024-07-10 S Sale
3.4
Opaleye Management Inc.
Large shareholder
13,061 -0.6%
2.31
US$30,145 		13,061 -0.6% 2.31 US$30,145
2024-07-11 2024-07-09 S Sale
3.4
Opaleye Management Inc.
Large shareholder
2,500 -3.0%
2.21
US$5,534 		2,500 -3.0% 2.21 US$5,534
2024-07-11 2024-07-09 S Sale
3.4
Opaleye Management Inc.
Large shareholder
5,997 -0.3%
2.21
US$13,276 		5,997 -0.3% 2.21 US$13,276
2024-07-03 2024-07-01 S Sale
3.4
Opaleye Management Inc.
Large shareholder
2,500 -2.8%
2.12
US$5,308 		2,500 -2.8% 2.12 US$5,308
2024-07-03 2024-07-01 S Sale
3.4
Opaleye Management Inc.
Large shareholder
5,788 -0.3%
2.12
US$12,290 		5,788 -0.3% 2.12 US$12,290
2024-06-28 2024-06-28 S Sale
3.4
Opaleye Management Inc.
Large shareholder
5,000 -5.6%
2.07
US$10,374 		5,000 -5.6% 2.07 US$10,374
2024-06-28 2024-06-28 S Sale
3.4
Opaleye Management Inc.
Large shareholder
12,994 -0.6%
2.07
US$26,960 		12,994 -0.6% 2.07 US$26,960
2024-06-28 2024-06-27 S Sale
3.4
Opaleye Management Inc.
Large shareholder
12,471 -12.2%
2.26
US$28,161 		12,471 -12.2% 2.26 US$28,161
2024-06-28 2024-06-27 S Sale
3.4
Opaleye Management Inc.
Large shareholder
34,103 -1.5%
2.26
US$77,008 		34,103 -1.5% 2.26 US$77,008
2024-06-27 2024-06-25 S Sale
3.4
Opaleye Management Inc.
Large shareholder
6,225 -5.7%
2.26
US$14,057 		6,225 -5.7% 2.26 US$14,057
2024-06-27 2024-06-25 S Sale
3.4
Opaleye Management Inc.
Large shareholder
6,500 -0.3%
2.26
US$14,678 		6,500 -0.3% 2.26 US$14,678
2024-05-31 2024-05-31 S Sale
3.4
Opaleye Management Inc.
Large shareholder
5,824 -5.1%
2.90
US$16,895 		5,824 -5.1% 2.90 US$16,895
2024-05-31 2024-05-30 S Sale
3.4
Opaleye Management Inc.
Large shareholder
9,230 -7.5%
2.94
US$27,113 		9,230 -7.5% 2.94 US$27,113
2024-05-23 2024-05-22 S Sale
3.4
Opaleye Management Inc.
Large shareholder
500 -0.4%
3.00
US$1,501 		500 -0.4% 3.00 US$1,501
2024-05-23 2024-05-22 S Sale
3.4
Opaleye Management Inc.
Large shareholder
9,300 -0.4%
3.02
US$28,095 		9,300 -0.4% 3.02 US$28,095
2024-05-23 2024-05-21 S Sale
3.4
Opaleye Management Inc.
Large shareholder
1,800 -1.4%
3.06
US$5,500 		1,800 -1.4% 3.06 US$5,500
2024-05-23 2024-05-21 S Sale
3.4
Opaleye Management Inc.
Large shareholder
31,200 -1.3%
3.06
US$95,338 		31,200 -1.3% 3.06 US$95,338
2024-05-17 2024-05-17 S Sale
3.4
Opaleye Management Inc.
Large shareholder
1,200 -0.9%
3.06
US$3,673 		1,200 -0.9% 3.06 US$3,673
2024-05-17 2024-05-17 S Sale
3.4
Opaleye Management Inc.
Large shareholder
2,750 -2.1%
3.33
US$9,152 		2,750 -2.1% 3.33 US$9,152
2024-05-17 2024-05-17 S Sale
3.4
Opaleye Management Inc.
Large shareholder
19,685 -0.8%
3.06
US$60,248 		19,685 -0.8% 3.06 US$60,248
2024-05-17 2024-05-17 S Sale
3.4
Opaleye Management Inc.
Large shareholder
47,250 -2.0%
3.33
US$157,253 		47,250 -2.0% 3.33 US$157,253
2024-05-10 2024-05-10 S Sale
3.4
Opaleye Management Inc.
Large shareholder
151,700 -6.0%
3.11
US$472,424 		151,700 -6.0% 3.11 US$472,424
2024-05-10 2024-05-09 S Sale
3.4
Opaleye Management Inc.
Large shareholder
30,600 -1.2%
3.09
US$94,526 		30,600 -1.2% 3.09 US$94,526
2022-09-15 2022-09-15 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
2,300 +1.8%
3.80
US$8,740 		2,300 +1.8% 3.80 US$8,740
2022-09-15 2022-09-15 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
5,000 +0.2%
3.80
US$19,000 		5,000 +0.2% 3.80 US$19,000
2022-09-15 2022-09-14 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
2,500 +2.0%
3.98
US$9,950 		2,500 +2.0% 3.98 US$9,950
2022-09-15 2022-09-14 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
14,100 +0.6%
3.98
US$56,118 		14,100 +0.6% 3.98 US$56,118
2022-08-15 2022-08-11 B Purchase
1.9
Shefferman Jesse

CEO and President

Executive Director
9,065 +1.0%
3.84
US$34,810 		9,065 +1.0% 3.84 US$34,810
2022-07-05 2022-06-30 B Purchase
2.4
BESHAR LUKE M
Non-Executive Director
10,000 +5.3%
3.10
US$31,000 		10,000 +5.3% 3.10 US$31,000
2022-04-08 2022-04-08 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
2,469 +105.4%
4.80
US$11,841 		2,469 +105.4% 4.80 US$11,841
2022-04-08 2022-04-08 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
5,322 +0.2%
4.80
US$25,523 		5,322 +0.2% 4.80 US$25,523
2022-04-08 2022-04-07 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
1,000 +0.8%
4.74
US$4,743 		1,000 +0.8% 4.74 US$4,743
2022-04-08 2022-04-07 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
1,345 +0.1%
4.74
US$6,380 		1,345 +0.1% 4.74 US$6,380
2022-03-16 2022-03-14 B Purchase
2.4
BESHAR LUKE M
Non-Executive Director
10,000 +5.6%
4.25
US$42,500 		10,000 +5.6% 4.25 US$42,500
2022-03-14 2022-03-10 B Purchase
2.4
BESHAR LUKE M
Non-Executive Director
10,000 +6.0%
4.46
US$44,555 		10,000 +6.0% 4.46 US$44,555
2022-01-31 2022-01-28 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
4,031 +3.4%
4.96
US$20,007 		4,031 +3.4% 4.96 US$20,007
2022-01-31 2022-01-28 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
20,000 +0.8%
4.96
US$99,264 		20,000 +0.8% 4.96 US$99,264
2021-12-22 2021-12-20 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
703 +0.0%
6.49
US$4,562 		703 +0.0% 6.49 US$4,562
2021-12-20 2021-12-17 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
490 +0.5%
6.60
US$3,234 		490 +0.5% 6.60 US$3,234
2021-12-20 2021-12-17 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
2,300 +0.1%
6.60
US$15,180 		2,300 +0.1% 6.60 US$15,180
2021-12-20 2021-12-16 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
1,063 +1.0%
6.41
US$6,815 		1,063 +1.0% 6.41 US$6,815
2021-12-20 2021-12-16 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
6,500 +0.3%
6.41
US$41,670 		6,500 +0.3% 6.41 US$41,670
2021-11-19 2021-11-18 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
1,000 +1.0%
6.98
US$6,980 		1,000 +1.0% 6.98 US$6,980
2021-11-19 2021-11-18 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
14,206 +0.6%
6.98
US$99,151 		14,206 +0.6% 6.98 US$99,151
Explore more

More insider trading research around Protara Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America